Health Medical Research

AI platforms for psychiatric patients show racial bias: Cedars-Sinai

HQ Team July 17, 2025: Artificial intelligence platforms for psychiatric patients are showing a pattern of racial bias by proposing different treatments for

Read More
Drugs Health Pharma

AstraZeneca’s trial drug for AL amyloidosis fails to meet survival goal

HQ Team July 16, 2025: AstraZeneca Plc’s investigational drug to treat AL amyloidosis, a rare and serious disease affecting the heart and kidneys,

Read More
Drugs Health Pharma

US regulator clears Biocon’s diabetic biosimilar product for Novolog

HQ Team July 15, 2025: The US Food and Drug Administration has approved a biosimilar product made by India’s Biocon Biologics Ltd., a

Read More
Drugs Health Pharma

ViiV to grant generic access to its HIV medicine to benefit 133 nations

HQ Team July 15, 2025: ViiV Healthcare, majority owned by GSK, has signed a pact with the UN-backed Medicines Patent Pool (MPP) to

Read More
Drugs Health Opinion

Neuroaesthetics: Art is not a luxury of soul, it is a language of the brain

HQ Team By Aparna S. July 15, 2025: Why does the curve of a statue stir something deep within our soul? Why do

Read More
Drugs Health Medical

Zimmer Biomet to buy Monogram Technologies for $177 million

HQ Team July 15, 2025: Zimmer Biomet Holdings, Inc. will acquire Monogram Technologies Inc., an orthopaedic robotics company, for $177 million to expand

Read More
Drugs Health Pharma

Funding shortage, conflicts hinder infant vaccination progress: UNICEF

HQ Team July 15, 2025: Global infant vaccination rates were up marginally last year, but shortfalls in funding, instability, and rising misinformation threaten

Read More
Drugs Health Pharma

Northern Arizona resident dies of pneumonic plague, first since 2007

HQ Team July 13, 2025: A patient in Northern Arizona, US, has died from pneumonic plague, the first such death in the country

Read More
Drugs Health Pharma

AbbVie inks $2 billion deal with IGI, bags antibody to fight cancer 

HQ Team July 10, 2025: AbbVie Inc. and IGI Therapeutics SA have signed a $2 billion licensing agreement that gives AbbVie access to

Read More
Drugs Health Pharma

Gilead, Global Fund to supply HIV prevention drug to two million people

HQ Team July 10, 2025: Gilead Sciences Inc. and the Global Fund have signed a pact to supply an HIV prevention drug at

Read More